BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more
BioGaia AB (publ) (BIOG-B) - Total Assets
Latest total assets as of September 2025: Skr1.49 Billion SEK
Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) holds total assets worth Skr1.49 Billion SEK as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioGaia AB (publ) - Total Assets Trend (2002–2024)
This chart illustrates how BioGaia AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioGaia AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2024)
BioGaia AB (publ)'s total assets of Skr1.49 Billion consist of 79.2% current assets and 20.8% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr1.22 Billion | 60.2% |
| Accounts Receivable | Skr222.47 Million | 10.9% |
| Inventory | Skr152.89 Million | 7.5% |
| Property, Plant & Equipment | Skr205.62 Million | 10.1% |
| Intangible Assets | Skr767.00K | 0.0% |
| Goodwill | Skr175.10 Million | 8.6% |
Asset Composition Trend (2002–2024)
This chart illustrates how BioGaia AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioGaia AB (publ)'s current assets represent 79.2% of total assets in 2024, a decrease from 79.9% in 2002.
- Cash Position: Cash and equivalents constituted 60.2% of total assets in 2024, down from 74.6% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, a decrease from 15.0% in 2002.
- Asset Diversification: The largest asset category is cash and equivalents at 60.2% of total assets.
BioGaia AB (publ) Competitors by Total Assets
Key competitors of BioGaia AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
BioGaia AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - BioGaia AB (publ) generates 0.70x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, BioGaia AB (publ) generates $ 17.28 in net profit.
BioGaia AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.27 | 7.78 | 12.51 |
| Quick Ratio | 6.27 | 7.78 | 11.97 |
| Cash Ratio | 4.15 | 5.79 | 0.00 |
| Working Capital | Skr924.08 Million | Skr 1.30 Billion | Skr 1.55 Billion |
BioGaia AB (publ) - Advanced Valuation Insights
This section examines the relationship between BioGaia AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.23 |
| Latest Market Cap to Assets Ratio | 0.35 |
| Asset Growth Rate (YoY) | -12.8% |
| Total Assets | Skr2.03 Billion |
| Market Capitalization | $714.80 Million USD |
Valuation Analysis
Below Book Valuation: The market values BioGaia AB (publ)'s assets below their book value (0.35 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BioGaia AB (publ)'s assets decreased by 12.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BioGaia AB (publ) (2002–2024)
The table below shows the annual total assets of BioGaia AB (publ) from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr2.03 Billion | -12.82% |
| 2023-12-31 | Skr2.33 Billion | +5.39% |
| 2022-12-31 | Skr2.21 Billion | +4.04% |
| 2021-12-31 | Skr2.13 Billion | +11.23% |
| 2020-12-31 | Skr1.91 Billion | +187.32% |
| 2019-12-31 | Skr665.90 Million | +0.90% |
| 2018-12-31 | Skr659.97 Million | +14.56% |
| 2017-12-31 | Skr576.11 Million | +17.82% |
| 2016-12-31 | Skr488.98 Million | +3.34% |
| 2015-12-31 | Skr473.18 Million | +13.85% |
| 2014-12-31 | Skr415.61 Million | +8.40% |
| 2013-12-31 | Skr383.42 Million | -25.84% |
| 2012-12-31 | Skr517.02 Million | +84.76% |
| 2011-12-31 | Skr279.83 Million | +22.83% |
| 2010-12-31 | Skr227.82 Million | +26.70% |
| 2009-12-31 | Skr179.81 Million | +16.53% |
| 2008-12-31 | Skr154.31 Million | +39.30% |
| 2007-12-31 | Skr110.77 Million | +22.05% |
| 2006-12-31 | Skr90.76 Million | +4.14% |
| 2005-12-31 | Skr87.15 Million | -19.68% |
| 2004-12-31 | Skr108.51 Million | -20.16% |
| 2003-12-31 | Skr135.90 Million | -15.92% |
| 2002-12-31 | Skr161.63 Million | -- |